Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
Public ClinicalTrials.gov record NCT00577473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomized, 6 Week, Parallel-group Design Clinical Trial in Patients With Mildly to Moderately Active Ulcerative Colitis to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of Asacol 4.8 g/day (800 mg tablet) versus Asacol 2.4 g/day (400 mg tablet
Study identification
- NCT ID
- NCT00577473
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 301 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2001 (Type not available)
- Primary completion
- Feb 2003 (Actual)
- Completion
- Feb 2003 (Actual)
- Last update posted
- Sep 16, 2011
2001 – 2003
United States locations
- U.S. sites
- 44
- U.S. states
- 24
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Francisco | California | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Facility | Golden | Colorado | — | — |
| Research Site | Bridgeport | Connecticut | — | — |
| Research Site | Fort Myers | Florida | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Jupiter | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Facility | Atlanta | Georgia | — | — |
| Research Facility | Decatur | Georgia | — | — |
| Research Site | Arlington Heights | Illinois | — | — |
| Research Site | Moline | Illinois | — | — |
| Research Site | Rockford | Illinois | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Metairie | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Laurel | Maryland | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | New Brunswick | New Jersey | — | — |
| Research Site | Somerville | New Jersey | — | — |
| Research Site | Great Neck | New York | — | — |
| Research Site | Pomona | New York | — | — |
| Research Facility | Poughkeepsie | New York | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Tulsa | Oklahoma | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Facility | Memphis | Tennessee | — | — |
| Research Facility | Nashville | Tennessee | — | — |
| Research Site | Fort Worth | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Burlington | Vermont | — | — |
| Research Site | Charlottesville | Virginia | — | — |
| Research Facility | Falls Church | Virginia | — | — |
| Research Site | Norfolk | Virginia | — | — |
| Research Site | Tacoma | Washington | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00577473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2011 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00577473 live on ClinicalTrials.gov.